AV

Archana Verma

Active Director Director DIN 07452010
DIN 07452010 First appointment Mar 2016 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2016
Shareholding value •••• Premium profile

About Archana Verma

Data last updated:

Archana Verma is a Director at Lucan Pharmaceuticals Private Limited (since 2016). The company operates in Healthcare. Lucan Pharmaceuticals Private Limited reported revenue of ₹50.6 Lakh (FY 2023).

DIN 07452010
Primary Designation Director
Industry Healthcare
First Appointment 22 Mar 2016
Oldest Company Age 10 yrs
Largest company Lucan Pharmaceuticals Private Limited · ₹50.6 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Mar 20162016₹50.6 Lakh (FY 2023)Active

Board colleagues of Archana Verma

NameDINCompanyDesignation
Rvikram07451986Lucan Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Lucan Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Archana Verma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Archana Verma

Archana Verma currently holds 1 directorship: Lucan Pharmaceuticals Private Limited (Director, since 22 Mar 2016, revenue ₹50.6 Lakh (FY 2023)).

Archana Verma was first appointed on 22 Mar 2016 as Director at Lucan Pharmaceuticals Private Limited.

The current boards of Archana Verma's companies include Rvikram (Lucan Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available